ArticleBriefings in bioinformatics2026
Cross-ancestry information transfer framework improves protein abundance prediction and protein-trait association identification.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multi-ancestry modeling improves fine-mapping resolution, protein prediction, and discovery for proteome-wide association studies.medRxiv : the preprint server for health sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Genetics-informed proteome-wide association studies (PWASs) provide an effective way to uncover proteomic mechanisms underlying complex diseases. PWAS relies on an ancestry-matched reference panel to model the impact of genetically determined protein expression on phenotype. However, reference panels from underrepresented populations remain relatively limited. We developed a multi-ancestry framework to enhance protein prediction in these populations by integrating diverse information-sharing strategies into a Multi-Ancestry Best-performing Model (MABM). Results indicated that MABM increased the prediction performance with higher performance observed in both cross-validation and an external dataset. Leveraging the Biobank Japan, we identified three times as many significant PWAS associations using MABM as using Lasso model. Notably, 47.5% of the MABM specific associations were reproduced in independent East Asian datasets with concordant effect sizes. Furthermore, MABM enhanced decision-making in gene/protein prioritization for functional validation for complex traits by validating well-established associations and uncovering novel trait-related candidates. The benefits of MABM were further validated in additional ancestries and demonstrated in brain tissue-based PWAS, underscoring its broad applicability. Our findings close critical gaps in multi-omics research among underrepresented populations and facilitate trait-relevant protein discovery in underrepresented populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.